ARCA Biopharma, Inc. (ABIO) Receives Heart Drug Patent
These days it has been all about drug patents going off market. So, when a new patent for a heart drug comes along there is good reason to stand up and take notice. Company revenue may rise or the company itself may get bought. Large gains are certainly possible, but only if the product can make it to market. ARCA Biopharma Inc., a biopharma company directed toward developing and commercializing genetic oriented products designed to combat heart failure and other cardiovascular issues, has recently made great head way in its work and reconceived a US patent for its efforts. The…